Allianz Asset Management
TBIO

Allianz Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Allianz Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,729
Closed -$846K – 2704
2021
Q2 		$846K Sell
30,729
-100,884
-77% -$1.98M ﹤0.01% 1805
2021
Q1 		$2.17M Sell
131,613
-25,120
-16% -$572K ﹤0.01% 1373
2020
Q4 		$2.89M Buy
156,733
+7,131
+5% +$128K ﹤0.01% 1212
2020
Q3 		$2.04M Buy
149,602
+19,894
+15% +$307K ﹤0.01% 1259
2020
Q2 		$2.33M Buy
+129,708
New +$1.96M ﹤0.01% 1544

Allianz Asset Management's TBIO Position: Q3 2021 in Review

Allianz Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 30,729 shares — an estimated $846K sold.

Allianz Asset Management first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $2.89M in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Allianz Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Allianz Asset Management sold 30,729 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $846K.
  • Allianz Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Allianz Asset Management's Translate Bio, Inc. Common Stock position peaked at $2.89M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.